Skip to content

The Relationship Between Lipid Peroxidation Products From Traumatic Brain Injury and Secondary Coagulation Disorders

The Relationship Between Lipid Peroxidation Products From Traumatic Brain Injury and Secondary Coagulation Disorders

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04274777
Enrollment
100
Registered
2020-02-18
Start date
2019-09-21
Completion date
2020-12-21
Last updated
2020-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coagulation Disorder, Traumatic Brain Injury

Keywords

Traumatic Brain Injury, Coagulation Disorder, Lipid Peroxidation

Brief summary

The purpose of this study is to observe the relationship between the level of lipid peroxidation products in serum of patients with traumatic brain injury and secondary coagulation disorders.

Detailed description

Uncontrolled hemorrhage after trauma is the leading cause of death. The mechanism of secondary coagulation dysfunction after trauma is special and complex, which has not been fully explained, leading to limited treatment and prevention methods. Coagulation disorders caused by traumatic brain injury is a systemic manifestation of local injury, which can activate platelets and promote platelet aggregation, activate thrombin, and promote the production of fibrin, leading to the formation of thrombosis. However, in non-injured areas, pro-coagulant molecules from damaged brain tissue reach the body through the broken blood-brain barrier, and also activate platelets and thrombin, promoting the formation of blood clots. Lipid peroxidation products are closely related to the occurrence of coagulation dysfunction. The effects lipid peroxidation products on platelets, thrombin and anticoagulant pathways may be a novel mechanism of secondary coagulation dysfunction in traumatic brain injury.

Interventions

None listed

Sponsors

Tang-Du Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

1. The interval between injury and admission is less than 24 hours 2. Age\>18yrs and age\<80yrs 3. Non-head abbreviated injury score \< 3 4. Did not undertake treatment before enrollment 5. Informed consent to participate in the study

Exclusion criteria

1. Take anticoagulants or antiplatelet drugs 2. Smoking history 3. Hemorrhagic or ischemic cerebrovascular disease occurred within six months 4. Other systemic diseases: uremia, cirrhosis, malignant tumor, etc 5. Patients with severe mental illness who are unable to communicate when diagnosed 6. Patients who refused follow-up

Design outcomes

Primary

MeasureTime frameDescription
The level of lipid peroxidation products in subjects' serumwithin 24 hours of traumathe level of high and low
Coagulation Disorderswithin 24 hours of traumaaPTT\>40s or INR\>1.4 or \<100 platelets per L

Secondary

MeasureTime frame
The 24-hour and 3-month Glasgow outcome score (GOS)from onset to three months

Countries

China

Contacts

Primary ContactWenxing Cui, M.D
wenxingcui@qq.com86-17367277315

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026